NYSEARCA:XDIV Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (XDIV) Price, Holdings, & News $25.31 -0.02 (-0.08%) As of 07/18/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (NYSEARCA:XDIV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get XDIV alerts:Sign Up Key Stats Today's Range$25.30▼$25.3850-Day Range$25.15▼$105.7352-Week Range$25.08▼$25.38Volume7,273 shsAverage Volume19,646 shsMarket Capitalization$8.10 millionAssets Under Management$34.02 millionDividend Yield0.00%Net Expense Ratio0.58%Aggregate RatingN/A ETF Overview Read More Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 ExpensesTypeXDIVLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.58%0.58%0.56%0.51%0.53%Other Expenses0.00%0.27%0.56%0.59%0.56%Total Expense0.58%0.65%0.76%0.74%0.73%Fee Waiver0.00%-0.23%-0.66%-0.71%-0.63%Net Expense0.58%0.62%0.63%0.58%0.60% Receive XDIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 and its competitors with MarketBeat's FREE daily newsletter. Email Address XDIV ETF News HeadlinesMetaurus U.S. Equity Ex-Dividend Fund-Series 2027 (NYSEARCA:XDIV) Shares Down 0.1% - Here's What HappenedJuly 19 at 2:48 AM | americanbankingnews.comXDIV: Suddenly, Canadian Dividend Stocks Look FantasticMay 12, 2025 | seekingalpha.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. July 19 at 2:00 AM | Porter & Company (Ad)XDIV: A Quality Dividend Fund With Sector-Specific Risks And Limited Growth PotentialDecember 21, 2024 | seekingalpha.comState Street Instl US Equity SvcOctober 24, 2024 | morningstar.comMTouchstone Dividend Equity ASeptember 6, 2024 | morningstar.comMSee More Headlines XDIV ETF - Frequently Asked Questions How have XDIV shares performed this year? Metaurus U.S. Equity Ex-Dividend Fund-Series 2027's stock was trading at $105.73 at the beginning of the year. Since then, XDIV stock has decreased by 76.1% and is now trading at $25.31. How do I buy shares of Metaurus U.S. Equity Ex-Dividend Fund-Series 2027? Shares of XDIV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 own? Based on aggregate information from My MarketBeat watchlists, some other companies that Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 investors own include Toronto-Dominion Bank (TD), Meta Platforms (META), NVIDIA (NVDA), Perseus Mining (PRU), Shopify (SHOP), iShares S&P/TSX Canadian Dividend Aristocrats Index ETF Common Class (CDZ) and Alphabet (GOOG). Fund Details IssuerMetaurus Advisors Fund NameUS Equity EX Dividend Fund-Series 2027 Tax ClassificationPartnership Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:XDIV Inception Date2/15/2018 Fund ManagerRichard Sandulli, Jamie Greenwald, Donald M. Callahan, Sean A. Dillon WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkSolactive US Ex-Dividends Index Series 2027 CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$34.02 million Average Daily Volume$2.68 thousand Discount/Premium-0.60% Administrator, Advisor and Custodian AdministratorSEI Investments Global Funds Services AdvisorMetaurus Advisors LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeWilmington Trust Company Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares320,000Beta1.09 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NYSEARCA:XDIV) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 Please log in to your account or sign up in order to add this asset to your watchlist. Share Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XDIV Stock Alerts